Abstract
Background High smoking prevalence leads to increased morbidity and mortality in individuals with depression/anxiety. Integrated interventions targeting both smoking and mood have been found to be more effective than those targeting smoking alone, but the mechanisms of change of these integrated interventions have not been investigated.
Aims This qualitative study aimed to investigate participants’ subjective experiences of the mechanisms underlying change in smoking behaviour following an integrated CBT-based intervention for smoking cessation and depression/anxiety.
Methods This study was embedded within an ongoing randomised controlled acceptability and feasibility trial (http://www.isrctn.com/ISRCTN99531779). Semi-structured interviews were conducted with 15 IAPT service users and data were analysed using thematic analysis.
Results Five themes were identified: (1) acquiring an increased awareness of smoking patterns, (2) developing individualised strategies, (3) practitioner style as “supportive but not lecture-y” (4) importance of regular sessions, and (5) having the opportunity to access intervention at “the right time”.
Conclusions These findings further our understanding of the mechanisms of change towards smoking cessation in this integrated intervention and highlight the need to emphasise and embed these components in manualised interventions to optimise therapeutic benefits and reduce smoking prevalence in people with depression/anxiety.
Relevance statement This study qualitatively investigated mechanisms underlying change in smoking behaviour following an integrated intervention for depression/anxiety and smoking cessation. Research shows interventions integrating smoking cessation and mood management are more effective than smoking cessation interventions alone; however further investigation is needed to understand mechanisms of change for integrated interventions. The current results identified key factors that were important for participants in the integrated intervention to reduce smoking. An improved understanding of mechanisms underlying change in smoking behaviour helps to identify therapist characteristics and treatment components that improve therapeutic outcomes which future research could investigate using a randomised controlled trial design.
Competing Interest Statement
Kim Fredman Stein, Jennifer Allen, Katherine Sawyer and Shadi Daryan have no conflicts of interest. Gemma Taylor has previously received funding from Pfizer, who manufacture smoking cessation products, for research unrelated to this study.
Clinical Protocols
Funding Statement
Kim Fredman Stein was funded by Health Education Englands DClinPsy Training Programme during the conduct of this study. Gemma Taylor is funded by a Cancer Research UK Population Researcher Postdoctoral Fellowship award (reference: C56067/A21330) and Cancer Research UK project award (reference: PPRCPJT\100023). Katherine Sawyer is funded by Cancer Research UK Population Researcher Postdoctoral Fellowship award (reference: C56067/A21330). Shadi Daryan is funded by Cancer Research UK project award (reference: PPRCPJT\100023). Jennifer Allen does not have a funding source related to this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NHS Research Ethics committee gave ethical approval for this work (Reference 19-245). Ethical approval for the IntEgrating Smoking Cessation treatment As part of routine Psychological care for dEpression and anxiety (ESCAPE) trial was obtained from a National Health Service Research Ethics Committee (19/03/2018, IRAS ID: 239339).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of Interest Kim Fredman Stein, Jennifer Allen, Katherine Sawyer and Shadi Daryan have no conflicts of interest. Gemma Taylor has previously received funding from Pfizer, who manufacture smoking cessation products, for research unrelated to this study.
Funding source Kim Fredman Stein was funded by Health Education England’s DClinPsy Training Programme during the conduct of this study. Gemma Taylor is funded by a Cancer Research UK Population Researcher Postdoctoral Fellowship award (reference: C56067/A21330) and Cancer Research UK project award (reference: PPRCPJT\100023). Katherine Sawyer is funded by Cancer Research UK Population Researcher Postdoctoral Fellowship award (reference: C56067/A21330). Shadi Daryan is funded by Cancer Research UK project award (reference: PPRCPJT\100023). Jennifer Allen does not have a funding source related to this study.
Ethical Approval Ethics approval for this study was received from the NHS Research Ethics Committee on 12 July 2019 (Reference 19-245). Ethical approval for the IntEgrating Smoking Cessation treatment As part of routine Psychological care for dEpression and anxiety (ESCAPE) trial was obtained from a National Health Service Research Ethics Committee (19/03/2018, IRAS ID: 239339).
Data Availability Anonymised transcript data are available for free via application to the University of Bath’s Research Data Service https://www.bath.ac.uk/guides/research-data-service/.
Data Availability
Anonymised transcript data are available for free via application to the University of Baths Research Data Service
